ReNeuron Group Plc (RENE), a British stem cell technology firm, said on Monday that it has appointed its Chief Financial Officer, Catherine Isted as Chief Executive Officer, with effect from September 1.
Following the departure of the former CEO Olav Hellebø in February, Isted has worked closely with the executive management team, led by Iain Ross.
Isted, who joined the ReNeuron as CFO in 2021, has around 25 years' of experience across the healthcare industry.
Isted had joined ReNeuron from Oxford Biomedica Plc, a cell and gene therapy firm, where she was instrumental in raising in excess of 110 million pounds.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.